Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors von SOEPENBERG, Otto, DUMEZ, Herlinde, LEFEBVRE, Patricia, ASSADOURIAN, Sylvie, SANDERINK, Ger-Jan, SPARREBOOM, Alex, VAN OOSTEROM, Allan T, VERWEIJ, Jaap, DE JONG, Floris A, DE JONGE, Maja J. A, THOMAS, José, ESKENS, Ferry A. L. M, VAN SCHAIK, Ron H. N, SELLESLACH, Johan, TER STEEG, Judith

Volltext

Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study von Dumez, Herlinde, Martens, Marc, Selleslach, Johan, Guetens, Gunter, De Boeck, Gert, Aerts, Rita, De Bruijn, Ernst A, Maes, Robert A, van Oosterom, Allan T

Volltext

Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients With Solid Tumors von SOEPENBERG, Otto, DUMEZ, Herlinde, SPARREBOOM, Alex, VAN OOSTEROM, A. T, VERWEIJ, Jaap, SEMIOND, Dorothee, DEJONGE, Maja J. A, ESKENS, Ferry A. L. M, TER STEEG, Judith, SELLESLACH, Johan, ASSADOURIAN, Sylvie, SANDERINK, Ger-Jan

Volltext